In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d
- PMID: 38830218
- DOI: 10.7326/ANNALS-24-00447-JC
In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d
Abstract
Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390:611-622. 38354140.
Conflict of interest statement
Comment on
-
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.N Engl J Med. 2024 Feb 15;390(7):611-622. doi: 10.1056/NEJMoa2304748. N Engl J Med. 2024. PMID: 38354140 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical